New England Journal of Medicine
-
February 27, 2025
VUMC part of new study validating curative therapy for sickle cell disease
Of 38 adults with severe SCD who participated in the study, more than 97% no longer required immunosuppressive therapy one year after the transplant. -
August 22, 2024
Yelena Bodien joins VUMC to advance efforts in research, treatment of brain disorders
Bodien, who will co-direct the Neuroimaging Core of the Critical Illness, Brain Dysfunction and Survivorship Center, has applied behavioral measures and advanced neuroimaging to improve the diagnosis and prognosis of severe brain injury. -
June 13, 2024
Multicenter study identifies method of preoxygenation that prevents hypoxemia and cardiac arrest during emergency tracheal intubation
Preoxygenation is the administration of supplemental oxygen prior to the start of a procedure to increase the content of oxygen in the lung and decrease the risk of hypoxemia -
March 26, 2024
GRADE Study expands results of major NIH-sponsored comparative study of glucose lowering medications in Type 2 diabetes
The study, which included more than 5,000 volunteers with Type 2 diabetes from diverse racial and ethnic groups, compared the treatments insulin glargine, liraglutide, glimepiride and sitagliptin. -
June 16, 2023
Study shows video laryngoscope increases successful intubation on first attempt
A Vanderbilt study study comparing the two types of laryngoscopes used in tracheal intubation of critically ill patients showed that the use of a video laryngoscope increased successful intubation on the first attempt, compared to the use of a direct laryngoscope, the standard approach for almost a century. -
March 30, 2023
New procedure helps patients avoid leg amputation
More than 75% of patients facing amputation from the most severe form of peripheral artery disease were able to keep their limb after an innovative treatment as part of a multicenter study published in the New England Journal of Medicine. -
March 2, 2023
High-dose flu vaccine beneficial for pediatric stem cell transplant patients
Vanderbilt was the lead site for an influenza vaccine study in pediatric allogeneic hematopoietic stem cell transplant recipients that may lead to a change in the current flu vaccine recommendations in this vulnerable population.